Tran Le was an engineering student at Stanford University when she tried to enroll in a clinical trial for her chronic ...

Clinical trials are underway in Colorado for a new drug that could extend a dog’s lifespan. Loyal, a San Francisco-based ...

By integrating Ryght AI's technology with QPS's experience and global network, the collaboration aims to streamline clinical ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

A new study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of University of Pennsylvania researchers demonstrates that a first-of-its-kind platform using artificial ...

US-based Halia Therapeutics’ new therapy will be put to a six-month-long trial that will involve 60 patients with type 2 ...

Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...

The patent, when formally approved, will reinforce protection for Silo's lead asset, SPC-15, an intranasal treatment ...